Kiniksa Pharmaceuticals Chief Medical Officer Paolini John F. exercised Options for 8,328 shares on 2026-09-01. The transactions also followed awards of 33,450 derivative securities and left him with 0 derivative securities, while his reported share ownership was 69,922 after a 4,029-share forfeiture at $79.28 per share.
Key Highlights
- Paolini John F. forfeited 4,029 Kiniksa shares at $79.28 per share on 1 September 2026.
- Kiniksa awarded Paolini John F. 33,450 derivative securities at $0 per share.
- Paolini John F. reported 0 derivative securities after exercising options.
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA) Chief Medical Officer Paolini John F. exercised options for 8,328 shares on 1 September 2026. His reported share ownership after those exercises was 73,951.
$79.28 Share Forfeiture and Derivative Awards
Paolini separately forfeited 4,029 shares at $79.28 per share on 1 September 2026, after which his reported share ownership was 69,922. Following those awards, Paolini’s derivative holdings were 26,750. He then exercised options covering 8,328 derivative securities at $0 per share. His derivative securities ownership after those exercises was 0.
FAQs
Q: How many Kiniksa Pharmaceuticals shares did Paolini John F. exercise?
A: Paolini John F. exercised options for 8,328 Kiniksa Pharmaceuticals shares on 1 September 2026. His reported share ownership following those exercises was 73,951 shares.
Q: What happened to Kiniksa derivative securities after the transactions?
A: Paolini John F. was awarded 33,450 derivative securities at $0 per share. After exercising options covering 8,328 derivative securities, his reported derivative holdings were 0.
Q: At what price did Paolini forfeit Kiniksa shares?
A: Paolini John F. forfeited 4,029 Kiniksa shares at $79.28 per share on 1 September 2026. His reported share ownership after that transaction was 69,922 shares.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.